Related Experiment Video
Updated: Dec 17, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus
1Department of Critical Care Medicine, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing 210000, Jiangsu, China. Corresponding author: Tang Jian,
Insights
Elevated D-dimer levels in COVID-19 patients correlate with increased inflammation and organ dysfunction. D-dimer can predict organ injury in coronavirus disease 2019 (COVID-19) patients.
Area of Science:
- Biomedical research
- Infectious disease pathology
- Clinical diagnostics
Background:
- Coronavirus disease 2019 (COVID-19) is associated with coagulopathy and systemic inflammation.
- Understanding biomarkers for disease severity and organ damage is crucial for patient management.
Purpose of the Study:
- To investigate the association between D-dimer levels and inflammatory markers.
- To explore the relationship between D-dimer and organ function in COVID-19 patients.
- To evaluate D-dimer's predictive value for organ injury.
Main Methods:
- Retrospective analysis of 72 COVID-19 patients' clinical and laboratory data.
- Comparison of inflammatory markers and cytokines between D-dimer normal and elevated groups.
- Linear regression analysis for D-dimer correlation with organ function parameters.
- Receiver operating characteristic (ROC) curve analysis to assess D-dimer's predictive performance for organ damage.
Main Results:
- Elevated D-dimer levels were observed in 55.6% of patients and correlated with disease severity.
- Patients with higher D-dimer showed increased inflammatory markers (WBC, NEU, PCT, hs-CRP, IL-6, IL-8, IL-2R, TNF-α) and impaired organ function (lower SpO2, PaO2/FiO2, PLT; higher RR, AST, TBil, DBil).
- ROC analysis indicated D-dimer has good predictive value for organ injury (AUC=0.889), with a sensitivity of 85.7% and specificity of 78.1% at a cut-off of 2.36 mg/L.
Conclusions:
- D-dimer levels are significantly associated with inflammatory status in COVID-19.
- D-dimer correlates with multiple indicators of organ dysfunction in COVID-19 patients.
- D-dimer serves as a valuable biomarker for predicting organ injury in COVID-19.
Objective:
To explore the relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019 (COVID-19).
Methods:
A retrospective study was conducted. The clinical data of 72 patients with COVID-19 admitted to intensive unit of Tongji Guanggu Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology in Wuhan, Hubei Province from February 10th to 29th in 2020 were collected, including their general information, routine blood test, coagulation function, inflammatory parameters, cytokines, and organ function related laboratory parameters at admission. The patients were divided into two groups, namely D-dimer normal group (< 0.5 mg/L) and D-dimer elevated group (≥ 0.5 mg/L). The differences of general data, inflammatory parameters and cytokines between the two groups were compared. Besides, the correlation between D-dimer and organ function was analyzed by linear regression. The change in sequential organ failure assessment (SOFA) between the first visit after the onset of the disease and admission to intensive unit ≥ 2 was defined as being combined with organ damage. Receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of D-dimer on organ damage in patients with COVID-19.
Results:
65.3% of the 72 patients had abnormal coagulation. The D-dimer level of COVID-19 patients gradually increased with the aggravation of the disease, and the levels of ordinary type (n = 14), severe type (n = 49), and critical type (n = 9) were 0.43 (0.22, 0.89), 0.66 (0.26, 1.36), and 2.65 (0.68, 15.45) mg/L, respectively, with statistically significant difference (P < 0.05). Thirty-two patients (44.4%) had normal D-dimer, and 40 (55.6%) had elevated D-dimer. Compared with the normal D-dimer group, the patients in the D-dimer elevated group were older (years old: 67.7±11.6 vs. 54.0±13.1), and the levels of white blood cell count (WBC), neutrophil count (NEU), procalcitonin (PCT), high-sensitivity C-reactive protein (hs-CRP), interleukins (IL-6, IL-8, IL-10), IL-2 receptor (IL-2R) and tumor necrosis factor-α (TNF-α) at admission were significantly higher [WBC (×109/L): 7.16 (5.55, 9.75) vs. 5.25 (4.59, 6.98), NEU (×109/L): 7.11±5.46 vs. 3.33±1.58, PCT (μg/L): 0.08 (0.06, 0.21) vs. 0.05 (0.04, 0.06), hs-CRP (mg/L): 27.9 (3.4, 58.8) vs. 1.3 (0.8, 6.6), IL-6 (ng/L): 11.80 (2.97, 30.61) vs. 1.98 (1.50, 4.73), IL-8 (ng/L): 19.90 (13.33, 42.28) vs. 9.40 (12.35, 15.30), IL-10 (ng/L): 5.00 (5.00, 8.38) vs. 5.00 (5.00, 5.00), IL-2R (kU/L): 907.90±458.42 vs. 572.13±274.55, TNF-α (ng/L): 10.94±5.95 vs. 7.77±3.67], while lymphocyte (LYM) and monocyte (MON) counts were lower [LYM (×109/L): 1.14±0.49 vs. 1.46±0.42, MON (×109/L): 0.63±0.25 vs. 0.87±0.21], with significant differences (all P < 0.05). Linear regression analysis showed that D-dimer level was negatively related with pulse oxygen saturation (SpO2), oxygenation index (PaO2/FiO2) and platelet count (PLT) with β values of -0.493, -11.615, and -0.018, respectively (all P < 0.05). However, D-dimer level was positively related with respiratory rate (RR), aspartate aminotransferase (AST), total bilirubin (TBil) and direct bilirubin (DBil) with β values of 0.485, 0.107, 0.291, and 0.404 (all P < 0.05). ROC curve analysis showed that the area under ROC curve (AUC) of D-dimer for predicting organ injury in COVID-19 patients was 0.889, and the 95% confidence interval (95%CI) was 0.753-1.000. When the optimal cut-off value was 2.36 mg/L, the sensitivity was 85.7%, and the specificity was 78.1%.
Conclusions:
D-dimer levels in COVID-19 patients are correlated with inflammatory factors and organ function, and it can be used to predict organ injury.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

